Time-related effects of estrogen withdrawal on proliferationand cell death-related events in MCF7 xenografts

International Journal of Cancer

Volumn 81, Issue 2, 1999, Pages 309-313

  Detre, Simone ^a   Salter, Janine ^a   Barnes, Diana M ^b   Riddler, Sharon ^c   Hills, Margaret ^a   Johnston, Stephen R D ^a   Gillett, Cheryl ^b   A'Hern, Roger ^a   Dowsett, Mitch ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c McElwain Laboratories   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CYCLIN D1; ESTROGEN; ESTROGEN RECEPTOR; IDOXIFENE; PROGESTERONE RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN PS2; TAMOXIFEN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CELL PROLIFERATION; CONTROLLED STUDY; ESTROGEN ACTIVITY; HORMONAL REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

ANIMALS; BREAST NEOPLASMS; CELL DEATH; CELL DIVISION; ESTRADIOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032964701     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990412)81:2<309::AID-IJC23>3.0.CO;2-S     Document Type: Article

References (24)

1. DEFRIEND, D.J. and 14 OTHERS, Investigation of a new pure antiestrogen (ICI 182,780) in women with primary breast cancer. Cancer Res., 54, 408-414 (1994).
2. DETRE, S., KING, N., SALTER, J., MACLENNAN, K., MCKINNA, J.A. and DOWSETT, M., Immunohistochemical and biochemical analysis of the oestrogen regulated protein pS2, and its relation with oestrogen receptor and progesterone receptor in breast cancer. J. clin. Pathol., 47, 240-244 (1994).
3. DETRE, S., SACCANI-JOTTI, G., KING, N. and DOWSETT, M., A quick score method for immunohistochemical semi-quantitation: validation for ER in breast cancer. J. clin. Pathol., 48, 876-878 (1995).
4. ELLIS, P.A., MAKRIS, A., BURTON, S.A., TITLEY, J., ORMEROD, M.G., SALTER, J., POWLES, T.J., SMITH, I.E. and DOWSETT, M., Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas. Brit. J. Cancer, 73, 640-643 (1996).
5. ELLIS, P.A. and 12 OTHRRS, Induction of apoptosis by tamoxifen and ICI 182,780 in primary breast cancer. Int. J. Cancer, 72, 608-613 (1997).
6. HOWELL, A., HARLAND, R., BARNES, D.M., BAILDAM, A.D., WILKINSON, M.J.S., HAYWARD, E. and SWINDELL, R.A., Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to therapy. Cancer Res., 47, 300-304 (1987).
7. HUANG, Y., RAY, S., REED, J.C., IBRADO, A.M., TANG, C., NAWABI, A. and BHALLA, K., Oestrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-tnduced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Res. Treat., 42, 73-81 (1997).
8. JOHNSTON, S.R.D., SMITH, I.E., HAYNES, B.P., JARMAN, M. and DOWSETT, M., The effects of a novel antioestrogen, idoxifene, on the growth of tamoxifen-sensitive and resistant MCF-7 xenografts in athymic mice. Brit. J. Cancer, 75, 804-808 (1997).
9. KATAYOSE, Y., KIM, M., RAKKAR, A.N., LI, Z., COWAN, K.H. and SETH, P., Promoting apoptosis: a novel activity associated with the cyclin dependent kinase inhibitor p27. Cancer Res., 57, 5441-5445 (1997).
10. KYPRIANOU, N., ENGLISH, H.F., DAVIDSON, N.E. and ISAACS, J.T., Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res., 51, 162-166 (1991).
11. MAINWARING, P.N., ELLIS, P.A., ANDERSON, E., HOWELL, A., NICHOLSON, R.I., ROBERTSON, J.F., SMITH, I.E., REED, J. and DOWSETT, M., Immunohistochemical expression of bcl-2 and bax is unaffected by the pure antioestrogen ICI 182,780 in human breast cancer. Proc. Amer. Assoc. Cancer Res., 38, 115 (1997).
12. MAINWARING, P.N., ELLIS, P.A., DETRE, S., SMITH, I.E. and DOWSETT, M., Comparison of in situ methods to assess DNA cleavage in apoptotic cells in patients with breast cancer. J. clin. Pathol., 51, 34-37 (1998).
13. MAKRIS, A., POWLES, T.J., ALLRED, D.C., ASHLEY, S.E., ORMEROD, M.G., TITLEY, J.C. and DOWSETT, M., Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with response. Breast Cancer Res. Treat., 48, 11-20 (1998).
14. NUÑEZ, A.M., JAKOWLEY, S. and BRIAND, J.P., Characterisation of the oestrogen induced pS2 protein secreted by the human breast cancer cell line MCF-7. Endocrinology, 121, 1759-1864 (1987).
15. OSBORNE, C.K., CORONADO, E.B. and ROBINSON. J.P., Human breast cancer in the athymic nude mouse: cytostatic effects of long term anti-oestrogen therapy. Europ. J. Cancer clin. Oncol., 23, 1189-1196 (1987).
16. OSBORNE, C.K., CORONADO-HEINSOHN, E.B., HILSENBECK, B.L., MCCUE, A.E., WAKELING, R.A., MCCLELLAND, R., MANNING, D.L. and NICHOLSON, R.I., Comparison of the effects of a pure steroidal antioestrogen with those of tamoxifen in a model of human breast cancer. J. nat. Cancer Inst., 87, 746-750 (1995).
17. kipl and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature (Med.), 3, 152-154 (1997).
18. REED, J.C., Bcl-2 and the regulation of cell death (review). J. Cell Biol., 124, 1-6 (1994).
19. SACCANI-JOTTI, G., JOHNSTON, S.R.D., SALTER, J., DETRE, S. and DOWSETT, M., Comparison of a new histochemical assay for oestrogen receptor in paraffin embedded breast carcinomas with the quantitative immunoassay. J. clin. Pathol., 47, 900-905 (1994).
20. SACEDA, M., LIPPMAN, M.E., CHAMBON, P., LINDSAY, R.L., PONGLIKITMONGKOL, M., PUENTE, M. and MARTIN, M.B., Regulation of the oestrogen receptor in MCF-7 cells by estradiol. Mol. Endocrinol., 2, 1157-1162 (1988).
21. SUTHERLAND, R.L., WATTS, C.K.W. and MUSGROVE, E.A., Cell cycle control by steroid hormones in breast cancer: implications for endocrine resistance. Endocrine-Related Cancer, 2, 87-96 (1995).
22. TEIXEIRA, C., REED, J.C. and PRATT, M.A.C., Oestrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 protooncogene expression in human breast cancer cells. Cancer Res., 55, 3902-3907 (1995).
23. WARRI, A.M., HUOVINEN, R.L., LAINE, A.M., MARTIKAINEN, P.M. and HARKONEN, K., Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vitro and in vivo. J. nat. Cancer Inst. 85, 1412-1418 (1993).
24. WIJSMAN, J.H., JONKER, R.R., KEIJZER, R., VAN DE VELDE, R., CORNELISSE, C.J. and VAN DIERENDONCK, J.H., A new method to detect apoptosis in paraffin sections: in situ end labelling of fragmented DNA. J. Histochem. Cytochem., 41, 7-12 (1993).